Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fagan

Showing results (61-70 of 260) with videos related to

Pageof 26
Sort By:
Current Pharmaceutical Design|May 12, 2012
Vascular protection to increase the safety of tissue plasminogen activator for strokeTauheed Ishrat, Sahar Soliman, Weihua Guan, et al.
Anesthesia and Analgesia|June 27, 2000
The effects of intracuff lidocaine on endotracheal-tube-induced emergence phenomena after general anesthesiaC Fagan, H P Frizelle, J Laffey, et al.
Experimental & Translational Stroke Medicine|June 16, 2016
Erratum to: Artery reopening is required for the neurorestorative effects of angiotensin modulation after experimental strokeAhmed Alhusban, Anna Kozak, Wael Eldahshan, et al.
Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission|March 23, 2011
Certification procedures for sirius red F3B (CI 35780, Direct red 80)R W Dapson, C Fagan, J A Kiernan, et al.
Neurochemical Research|November 7, 2013
Candesartan reduces the hemorrhage associated with delayed tissue plasminogen activator treatment in rat embolic strokeTauheed Ishrat, Bindu Pillai, Adviye Ergul, et al.
Clinical Pharmacology and Therapeutics|March 1, 1986
Effects of meals on hemodynamics: implications for antihypertensive drug studiesT C Fagan, K A Conrad, J H Mar, et al.
Pharmacotherapy|March 11, 2015
Vascular protection with dipeptidyl peptidase-IV inhibitors in diabetes: experimental and clinical therapeuticsHeba A Ahmed, Dianne W May, Susan C Fagan, et al.
Journal of Food Science|September 13, 2024
Characterization of cooked cheese flavor: Volatile componentsRosa C Sullivan, Fiyinfolu Makinwa, Colette C Fagan, et al.
Neurology|April 1, 1995
Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapyM P Bowes, R Rothlein, S C Fagan, et al.
Translational Stroke Research|March 13, 2014
Hyperglycemia, acute ischemic stroke, and thrombolytic therapySherif Hafez, Maha Coucha, Askiel Bruno, et al.
Pageof 26

Showing results (61-70 of 260) with videos related to

Sort By:
Pageof 26
Current Pharmaceutical Design|May 12, 2012
Vascular protection to increase the safety of tissue plasminogen activator for strokeTauheed Ishrat, Sahar Soliman, Weihua Guan, et al.
Anesthesia and Analgesia|June 27, 2000
The effects of intracuff lidocaine on endotracheal-tube-induced emergence phenomena after general anesthesiaC Fagan, H P Frizelle, J Laffey, et al.
Experimental & Translational Stroke Medicine|June 16, 2016
Erratum to: Artery reopening is required for the neurorestorative effects of angiotensin modulation after experimental strokeAhmed Alhusban, Anna Kozak, Wael Eldahshan, et al.
Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission|March 23, 2011
Certification procedures for sirius red F3B (CI 35780, Direct red 80)R W Dapson, C Fagan, J A Kiernan, et al.
Neurochemical Research|November 7, 2013
Candesartan reduces the hemorrhage associated with delayed tissue plasminogen activator treatment in rat embolic strokeTauheed Ishrat, Bindu Pillai, Adviye Ergul, et al.
Clinical Pharmacology and Therapeutics|March 1, 1986
Effects of meals on hemodynamics: implications for antihypertensive drug studiesT C Fagan, K A Conrad, J H Mar, et al.
Pharmacotherapy|March 11, 2015
Vascular protection with dipeptidyl peptidase-IV inhibitors in diabetes: experimental and clinical therapeuticsHeba A Ahmed, Dianne W May, Susan C Fagan, et al.
Journal of Food Science|September 13, 2024
Characterization of cooked cheese flavor: Volatile componentsRosa C Sullivan, Fiyinfolu Makinwa, Colette C Fagan, et al.
Neurology|April 1, 1995
Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapyM P Bowes, R Rothlein, S C Fagan, et al.
Translational Stroke Research|March 13, 2014
Hyperglycemia, acute ischemic stroke, and thrombolytic therapySherif Hafez, Maha Coucha, Askiel Bruno, et al.
Pageof 26